Diagnostic Testing Market Size to Exceed US$ 348.75 Billion by 2030 | Says Precedence Research

According to Precedence Research, during the forecast period of 2022 to 2030, the global diagnostic testing market is estimated to develop at a compound annual growth rate (CAGR) of 8.63%. The global diagnostic testing market was valued at USD 165.58 billion in 2021, and it is predicted to exceed USD 348.75 billion by 2030. The study investigates several elements and their consequences on the growth of the diagnostic testing market.

Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1984

This report focuses on diagnostic testing market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall diagnostic testing market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.

Report Scope of the Diagnostic Testing Market

The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

In-Depth Analysis on Competitive Landscape

The report sheds light on leading manufacturers of diagnostic testing, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of diagnostic testing has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the diagnostic testing market.

Some of the prominent players in the diagnostic testing market include:

• F-Hoffman La-Rcohe Ltd. (Switzerland)
• Danaher (US)
• BD (US)
• Thermo Fisher Scientific Inc. (US)
• ACON Laboratories Inc. (US)
• Hemosure, Inc. (US)
• MicroGen Diagnostics (US)
• Grifols, S.A (Spain)
• BODITECH MED INC. (South Korea)
• Chembio Diagnostic Systems, Inc. (US)
• Nanoentek (South Korea)
• DiaSorin S.p.A. (Italy)
• Bio-Rad Laboratories, Inc. (US)
• BIOMEDOMICS INC (US)
• EKF Diagnostics Holdings plc (UK)
• Siemens Healthcare GmbH (Germany)
• PerkinElmer Inc. (US)
• bioMérieux SA (France)
• ARKRAY USA, Inc. (US)
• Biohit Oyj (Finland)
• Quidel Corporation (US)
• Illumina, Inc. (US)
• Lamdagen Corporation (US)
• LifeSign LLC. (US)
• Medixbiochemica (Finaland)
• Nova Biomedical (US)
• Ortho Clinical Diagnostics (US)
• Sannuo Biosensing Co., Ltd. (US)
• STRECK (US)
• Sysmex Corporation (Japan)

Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/1984

Segments Covered in the Report

By Type

• Clinical Diagnostic
• Home Diagnostic

By Application

• Cardiology
• Oncology
• Neurology
• Orthopedics
• Gastroenterology
• Gynecology
• Odontology
• Others

By Approach

• Molecular Diagnostic Instrument
• In-Vitro Diagnostic Instrument
• Point Of Care Testing Instrument

By Solution

• Services
• Products

By Technology

• Immunoassay-Based
• PCR-Based
• Next-generation Sequencing
• Spectroscopy-Based
• Chromatography-Based
• Microfluidics
• Substrate Technology
• Others

By Mode of Testing

• Prescription Based Testing
• OTC Testing

By Sample Type

• Urine
• Saliva
• Blood
• Hair
• Sweat
• Others

By Testing Type

• Biochemistry
• Hematology
• Microbiology
• Histopathology
• Others

By Age

• Pediatric
• Adult & Geriatric

By Distribution Channel

• Direct Tenders
• Retail Sales
• Online Sales

By End User

• Hospitals, Diagnostic Center
• Research Labs and Institutes
• Research Institute
• Homecare
• Blood Banks
• Specialty Clinics
• Ambulatory Surgical Centers
• Others

Regional Segmentation

• Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
• Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
• North America [United States, Canada, Mexico]
• South America [Brazil, Argentina, Columbia, Chile, Peru]
• Middle East & Africa [GCC, North Africa, South Africa]

Some of the important ones are:

• What can be the best investment choices for venturing into new product and service lines?
• What value propositions should businesses aim at while making new research and development funding?
• Which regulations will be most helpful for stakeholders to boost their supply chain network?
• Which regions might see the demand maturing in certain segments in near future?
• What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
• Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
• Which government regulations might challenge the status of key regional markets?
• How will the emerging political and economic scenario affect opportunities in key growth areas?
• What are some of the value-grab opportunities in various segments?
• What will be the barrier to entry for new players in the market?

Table of Contents

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Ages

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Eleven Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Diagnostic Testing Market, By Type

7.1. Diagnostic Testing Market, by Type, 2022-2030

7.1.1. Clinical Diagnostic

7.1.1.1. Market Revenue and Forecast (2017-2030)

7.1.2. Home Diagnostic

7.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Diagnostic Testing Market, By Application

8.1. Diagnostic Testing Market, by Application, 2022-2030

8.1.1. Cardiology

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Oncology

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Neurology

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Orthopedics

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Gastroenterology

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Gynecology

8.1.6.1. Market Revenue and Forecast (2017-2030)

8.1.7. Odontology

8.1.8.1. Market Revenue and Forecast (2017-2030)

8.1.9. Others

8.1.9.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Diagnostic Testing Market, By Approach

9.1. Diagnostic Testing Market, by Approach, 2022-2030

9.1.1. Molecular Diagnostic Instrument

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. In-Vitro Diagnostic Instrument

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Point Of Care Testing Instrument

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Diagnostic Testing Market, By Solution

10.1. Diagnostic Testing Market, by Solution, 2022-2030

10.1.1. Services

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Products

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Diagnostic Testing Market, By Technology

11.1. Diagnostic Testing Market, by Technology, 2022-2030

11.1.1. Immunoassay-Based

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. PCR-Based

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Next-generation Sequencing

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Spectroscopy-Based

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Chromatography-Based

11.1.5.1. Market Revenue and Forecast (2017-2030)

11.1.6. Microfluidics

11.1.6.1. Market Revenue and Forecast (2017-2030)

11.1.7. Substrate Technology

11.1.7.1. Market Revenue and Forecast (2017-2030)

11.1.8. Others

11.1.8.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Diagnostic Testing Market, By Mode of Testing

12.1. Diagnostic Testing Market, by Mode of Testing, 2022-2030

12.1.1. Prescription Based Testing

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. OTC Testing

12.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Diagnostic Testing Market, By Sample Type

13.1. Diagnostic Testing Market, by Sample Type, 2022-2030

13.1.1. Urine

13.1.1.1. Market Revenue and Forecast (2017-2030)

13.1.2. Saliva

13.1.2.1. Market Revenue and Forecast (2017-2030)

13.1.3. Blood

13.1.3.1. Market Revenue and Forecast (2017-2030)

13.1.4. Hair

13.1.4.1. Market Revenue and Forecast (2017-2030)

13.1.5. Sweat

13.1.5.1. Market Revenue and Forecast (2017-2030)

13.1.6. Others

13.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 14. Global Diagnostic Testing Market, By Testing Type

14.1. Diagnostic Testing Market, by Testing Type, 2022-2030

14.1.1. Biochemistry

14.1.1.1. Market Revenue and Forecast (2017-2030)

14.1.2. Hematology

14.1.2.1. Market Revenue and Forecast (2017-2030)

14.1.3. Microbiology

14.1.3.1. Market Revenue and Forecast (2017-2030)

14.1.4. Histopathology

14.1.4.1. Market Revenue and Forecast (2017-2030)

14.1.5. Others

14.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 15. Global Diagnostic Testing Market, By Age

15.1. Diagnostic Testing Market, by Age, 2022-2030

15.1.1. Pediatric

15.1.1.1. Market Revenue and Forecast (2017-2030)

15.1.2. Adult & Geriatric

15.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 16. Global Diagnostic Testing Market, By Distribution Channel

16.1. Diagnostic Testing Market, by Distribution Channel, 2022-2030

16.1.1. Direct Tenders

16.1.1.1. Market Revenue and Forecast (2017-2030)

16.1.2. Retail Sales

16.1.2.1. Market Revenue and Forecast (2017-2030)

16.1.3. Online Sales

16.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 17. Global Diagnostic Testing Market, By End User

17.1. Diagnostic Testing Market, by End User, 2022-2030

17.1.1. Hospitals, Diagnostic Center

17.1.1.1. Market Revenue and Forecast (2017-2030)

17.1.2. Research Labs and Institutes

17.1.2.1. Market Revenue and Forecast (2017-2030)

17.1.3. Research Institute

17.1.3.1. Market Revenue and Forecast (2017-2030)

17.1.4. Homecare

17.1.4.1. Market Revenue and Forecast (2017-2030)

17.1.5. Blood Banks

17.1.5.1. Market Revenue and Forecast (2017-2030)

17.1.6. Specialty Clinics

17.1.6.1. Market Revenue and Forecast (2017-2030)

17.1.7. Ambulatory Surgical Centers

17.1.7.1. Market Revenue and Forecast (2017-2030)

17.1.8. Others

17.1.8.1. Market Revenue and Forecast (2017-2030)

 

Chapter 18. Global Diagnostic Testing Market, Regional Estimates and Trend Forecast

18.1. North America

18.1.1. Market Revenue and Forecast, by Type (2017-2030)

18.1.2. Market Revenue and Forecast, by Application (2017-2030)

18.1.3. Market Revenue and Forecast, by Approach (2017-2030)

18.1.4. Market Revenue and Forecast, by Solution (2017-2030)

18.1.5. Market Revenue and Forecast, by Technology (2017-2030)

18.1.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.1.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.1.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.1.9. Market Revenue and Forecast, by Age (2017-2030)

18.1.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.1.11. Market Revenue and Forecast, by End User (2017-2030)

18.1.12. U.S.

18.1.12.1. Market Revenue and Forecast, by Type (2017-2030)

18.1.12.2. Market Revenue and Forecast, by Application (2017-2030)

18.1.12.3. Market Revenue and Forecast, by Approach (2017-2030)

18.1.12.4. Market Revenue and Forecast, by Solution (2017-2030)

18.1.12.5. Market Revenue and Forecast, by Technology (2017-2030)

18.1.12.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.1.12.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.1.12.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.1.12.9. Market Revenue and Forecast, by Age (2017-2030)

18.1.12.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.1.12.11. Market Revenue and Forecast, by End User (2017-2030)

18.1.12.12. Market Revenue and Forecast, by December (2017-2030)

18.1.12.13. Market Revenue and Forecast, by Eleven (2017-2030)

18.1.13. Rest of North America

18.1.13.1. Market Revenue and Forecast, by Type (2017-2030)

18.1.13.2. Market Revenue and Forecast, by Application (2017-2030)

18.1.13.3. Market Revenue and Forecast, by Approach (2017-2030)

18.1.13.4. Market Revenue and Forecast, by Solution (2017-2030)

18.1.13.5. Market Revenue and Forecast, by Technology (2017-2030)

18.1.13.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.1.13.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.1.13.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.1.13.9. Market Revenue and Forecast, by Age (2017-2030)

18.1.13.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.1.13.11. Market Revenue and Forecast, by End User (2017-2030)

18.2. Europe

18.2.1. Market Revenue and Forecast, by Type (2017-2030)

18.2.2. Market Revenue and Forecast, by Application (2017-2030)

18.2.3. Market Revenue and Forecast, by Approach (2017-2030)

18.2.4. Market Revenue and Forecast, by Solution (2017-2030)

18.2.5. Market Revenue and Forecast, by Technology (2017-2030)

18.2.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.2.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.2.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.2.9. Market Revenue and Forecast, by Age (2017-2030)

18.2.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.2.11. Market Revenue and Forecast, by End User (2017-2030)

18.2.12. UK

18.2.12.1. Market Revenue and Forecast, by Type (2017-2030)

18.2.12.2. Market Revenue and Forecast, by Application (2017-2030)

18.2.12.3. Market Revenue and Forecast, by Approach (2017-2030)

18.2.12.4. Market Revenue and Forecast, by Solution (2017-2030)

18.2.12.5. Market Revenue and Forecast, by Technology (2017-2030)

18.2.12.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.2.12.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.2.12.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.2.12.9. Market Revenue and Forecast, by Age (2017-2030)

18.2.12.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.2.12.11. Market Revenue and Forecast, by End User (2017-2030)

18.2.13. Germany

18.2.13.1. Market Revenue and Forecast, by Type (2017-2030)

18.2.13.2. Market Revenue and Forecast, by Application (2017-2030)

18.2.13.3. Market Revenue and Forecast, by Approach (2017-2030)

18.2.13.4. Market Revenue and Forecast, by Solution (2017-2030)

18.2.13.5. Market Revenue and Forecast, by Technology (2017-2030)

18.2.13.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.2.13.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.2.13.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.2.13.9. Market Revenue and Forecast, by Age (2017-2030)

18.2.13.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.2.13.11. Market Revenue and Forecast, by End User (2017-2030)

18.2.14. France

18.2.14.1. Market Revenue and Forecast, by Type (2017-2030)

18.2.14.2. Market Revenue and Forecast, by Application (2017-2030)

18.2.14.3. Market Revenue and Forecast, by Approach (2017-2030)

18.2.14.4. Market Revenue and Forecast, by Solution (2017-2030)

18.2.14.5. Market Revenue and Forecast, by Technology (2017-2030)

18.2.14.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.2.14.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.2.14.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.2.14.9. Market Revenue and Forecast, by Age (2017-2030)

18.2.14.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.2.14.11. Market Revenue and Forecast, by End User (2017-2030)

18.2.15. Rest of Europe

18.2.15.1. Market Revenue and Forecast, by Type (2017-2030)

18.2.15.2. Market Revenue and Forecast, by Application (2017-2030)

18.2.15.3. Market Revenue and Forecast, by Approach (2017-2030)

18.2.15.4. Market Revenue and Forecast, by Solution (2017-2030)

18.2.15.5. Market Revenue and Forecast, by Technology (2017-2030)

18.2.15.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.2.15.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.2.15.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.2.15.9. Market Revenue and Forecast, by Age (2017-2030)

18.2.15.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.2.15.11. Market Revenue and Forecast, by End User (2017-2030)

18.3. APAC

18.3.1. Market Revenue and Forecast, by Type (2017-2030)

18.3.2. Market Revenue and Forecast, by Application (2017-2030)

18.3.3. Market Revenue and Forecast, by Approach (2017-2030)

18.3.4. Market Revenue and Forecast, by Solution (2017-2030)

18.3.5. Market Revenue and Forecast, by Technology (2017-2030)

18.3.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.3.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.3.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.3.9. Market Revenue and Forecast, by Age (2017-2030)

18.3.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.3.11. Market Revenue and Forecast, by End User (2017-2030)

18.3.12. India

18.3.12.1. Market Revenue and Forecast, by Type (2017-2030)

18.3.12.2. Market Revenue and Forecast, by Application (2017-2030)

18.3.12.3. Market Revenue and Forecast, by Approach (2017-2030)

18.3.12.4. Market Revenue and Forecast, by Solution (2017-2030)

18.3.12.5. Market Revenue and Forecast, by Technology (2017-2030)

18.3.12.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.3.12.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.3.12.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.3.12.9. Market Revenue and Forecast, by Age (2017-2030)

18.3.12.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.3.12.11. Market Revenue and Forecast, by End User (2017-2030)

18.3.13. China

18.3.13.1. Market Revenue and Forecast, by Type (2017-2030)

18.3.13.2. Market Revenue and Forecast, by Application (2017-2030)

18.3.13.3. Market Revenue and Forecast, by Approach (2017-2030)

18.3.13.4. Market Revenue and Forecast, by Solution (2017-2030)

18.3.13.5. Market Revenue and Forecast, by Technology (2017-2030)

18.3.13.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.3.13.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.3.13.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.3.13.9. Market Revenue and Forecast, by Age (2017-2030)

18.3.13.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.3.13.11. Market Revenue and Forecast, by End User (2017-2030)

18.3.14. Japan

18.3.14.1. Market Revenue and Forecast, by Type (2017-2030)

18.3.14.2. Market Revenue and Forecast, by Application (2017-2030)

18.3.14.3. Market Revenue and Forecast, by Approach (2017-2030)

18.3.14.4. Market Revenue and Forecast, by Solution (2017-2030)

18.3.14.5. Market Revenue and Forecast, by Technology (2017-2030)

18.3.14.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.3.14.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.3.14.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.3.14.9. Market Revenue and Forecast, by Age (2017-2030)

18.3.14.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.3.14.11. Market Revenue and Forecast, by End User (2017-2030)

18.3.15. Rest of APAC

18.3.15.1. Market Revenue and Forecast, by Type (2017-2030)

18.3.15.2. Market Revenue and Forecast, by Application (2017-2030)

18.3.15.3. Market Revenue and Forecast, by Approach (2017-2030)

18.3.15.4. Market Revenue and Forecast, by Solution (2017-2030)

18.3.15.5. Market Revenue and Forecast, by Technology (2017-2030)

18.3.15.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.3.15.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.3.15.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.3.15.9. Market Revenue and Forecast, by Age (2017-2030)

18.3.15.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.3.15.11. Market Revenue and Forecast, by End User (2017-2030)

18.4. MEA

18.4.1. Market Revenue and Forecast, by Type (2017-2030)

18.4.2. Market Revenue and Forecast, by Application (2017-2030)

18.4.3. Market Revenue and Forecast, by Approach (2017-2030)

18.4.4. Market Revenue and Forecast, by Solution (2017-2030)

18.4.5. Market Revenue and Forecast, by Technology (2017-2030)

18.4.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.4.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.4.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.4.9. Market Revenue and Forecast, by Age (2017-2030)

18.4.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.4.11. Market Revenue and Forecast, by End User (2017-2030)

18.4.12. GCC

18.4.12.1. Market Revenue and Forecast, by Type (2017-2030)

18.4.12.2. Market Revenue and Forecast, by Application (2017-2030)

18.4.12.3. Market Revenue and Forecast, by Approach (2017-2030)

18.4.12.4. Market Revenue and Forecast, by Solution (2017-2030)

18.4.12.5. Market Revenue and Forecast, by Technology (2017-2030)

18.4.12.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.4.12.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.4.12.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.4.12.9. Market Revenue and Forecast, by Age (2017-2030)

18.4.12.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.4.12.11. Market Revenue and Forecast, by End User (2017-2030)

18.4.13. North Africa

18.4.13.1. Market Revenue and Forecast, by Type (2017-2030)

18.4.13.2. Market Revenue and Forecast, by Application (2017-2030)

18.4.13.3. Market Revenue and Forecast, by Approach (2017-2030)

18.4.13.4. Market Revenue and Forecast, by Solution (2017-2030)

18.4.13.5. Market Revenue and Forecast, by Technology (2017-2030)

18.4.13.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.4.13.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.4.13.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.4.13.9. Market Revenue and Forecast, by Age (2017-2030)

18.4.13.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.4.13.11. Market Revenue and Forecast, by End User (2017-2030)

18.4.14. South Africa

18.4.14.1. Market Revenue and Forecast, by Type (2017-2030)

18.4.14.2. Market Revenue and Forecast, by Application (2017-2030)

18.4.14.3. Market Revenue and Forecast, by Approach (2017-2030)

18.4.14.4. Market Revenue and Forecast, by Solution (2017-2030)

18.4.14.5. Market Revenue and Forecast, by Technology (2017-2030)

18.4.14.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.4.14.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.4.14.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.4.14.9. Market Revenue and Forecast, by Age (2017-2030)

18.4.14.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.4.14.11. Market Revenue and Forecast, by End User (2017-2030)

18.4.15. Rest of MEA

18.4.15.1. Market Revenue and Forecast, by Type (2017-2030)

18.4.15.2. Market Revenue and Forecast, by Application (2017-2030)

18.4.15.3. Market Revenue and Forecast, by Approach (2017-2030)

18.4.15.4. Market Revenue and Forecast, by Solution (2017-2030)

18.4.15.5. Market Revenue and Forecast, by Technology (2017-2030)

18.4.15.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.4.15.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.4.15.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.4.15.9. Market Revenue and Forecast, by Age (2017-2030)

18.4.15.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.4.15.11. Market Revenue and Forecast, by End User (2017-2030)

18.5. Latin America

18.5.1. Market Revenue and Forecast, by Type (2017-2030)

18.5.2. Market Revenue and Forecast, by Application (2017-2030)

18.5.3. Market Revenue and Forecast, by Approach (2017-2030)

18.5.4. Market Revenue and Forecast, by Solution (2017-2030)

18.5.5. Market Revenue and Forecast, by Technology (2017-2030)

18.5.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.5.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.5.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.5.9. Market Revenue and Forecast, by Age (2017-2030)

18.5.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.5.11. Market Revenue and Forecast, by End User (2017-2030)

18.5.12. Brazil

18.5.12.1. Market Revenue and Forecast, by Type (2017-2030)

18.5.12.2. Market Revenue and Forecast, by Application (2017-2030)

18.5.12.3. Market Revenue and Forecast, by Approach (2017-2030)

18.5.12.4. Market Revenue and Forecast, by Solution (2017-2030)

18.5.12.5. Market Revenue and Forecast, by Technology (2017-2030)

18.5.12.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.5.12.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.5.12.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.5.12.9. Market Revenue and Forecast, by Age (2017-2030)

18.5.12.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.5.12.11. Market Revenue and Forecast, by End User (2017-2030)

18.5.13. Rest of LATAM

18.5.13.1. Market Revenue and Forecast, by Type (2017-2030)

18.5.13.2. Market Revenue and Forecast, by Application (2017-2030)

18.5.13.3. Market Revenue and Forecast, by Approach (2017-2030)

18.5.13.4. Market Revenue and Forecast, by Solution (2017-2030)

18.5.13.5. Market Revenue and Forecast, by Technology (2017-2030)

18.5.13.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.5.13.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.5.13.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.5.13.9. Market Revenue and Forecast, by Age (2017-2030)

18.5.13.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.5.13.11. Market Revenue and Forecast, by End User (2017-2030)

Chapter 19. Company Profiles

19.1. F-Hoffman La-Rcohe Ltd. (Switzerland)

19.1.1. Company Overview

19.1.2. Product Offerings

19.1.3. Financial Performance

19.1.4. Recent Initiatives

19.2. Danaher (US)

19.2.1. Company Overview

19.2.2. Product Offerings

19.2.3. Financial Performance

19.2.4. Recent Initiatives

19.3. BD (US)

19.3.1. Company Overview

19.3.2. Product Offerings

19.3.3. Financial Performance

19.3.4. Recent Initiatives

19.4. Thermo Fisher Scientific Inc. (US)

19.4.1. Company Overview

19.4.2. Product Offerings

19.4.3. Financial Performance

19.4.4. Recent Initiatives

19.5. ACON Laboratories Inc. (US)

19.5.1. Company Overview

19.5.2. Product Offerings

19.5.3. Financial Performance

19.5.4. Recent Initiatives

19.6. Hemosure, Inc. (US)

19.6.1. Company Overview

19.6.2. Product Offerings

19.6.3. Financial Performance

19.6.4. Recent Initiatives

19.7. MicroGen Diagnostics (US)

19.7.1. Company Overview

19.7.2. Product Offerings

19.7.3. Financial Performance

19.7.4. Recent Initiatives

19.8. Grifols, S.A (Spain)

19.8.1. Company Overview

19.8.2. Product Offerings

19.8.3. Financial Performance

19.8.4. Recent Initiatives

19.9. BODITECH MED INC. (South Korea)

19.9.1. Company Overview

19.9.2. Product Offerings

19.9.3. Financial Performance

19.9.4. Recent Initiatives

19.10. Chembio Diagnostic Systems, Inc. (US)

19.10.1. Company Overview

19.10.2. Product Offerings

19.10.3. Financial Performance

19.10.4. Recent Initiatives

Chapter 20. Research Methodology

20.1. Primary Research

20.2. Secondary Research

20.3. Assumptions

Chapter 21. Appendix

21.1. About Us

21.2. Glossary of Terms

Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1984

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com